Therapeutic Targets and Personalized Medicine in Cardiac Disease
- PMID: 38003849
- PMCID: PMC10671984
- DOI: 10.3390/jpm13111534
Therapeutic Targets and Personalized Medicine in Cardiac Disease
Abstract
Despite extensive research that has achieved notable advancements over the last decades, cardiovascular disease (CVD) remains the leading cause of death worldwide, with millions affected around the world [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Revolutionizing Cardiac Care: A Comprehensive Narrative Review of Cardiac Rehabilitation and the Evolution of Cardiovascular Medicine.Cureus. 2023 Oct 4;15(10):e46469. doi: 10.7759/cureus.46469. eCollection 2023 Oct. Cureus. 2023. PMID: 37927717 Free PMC article. Review.
-
Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management.Phytomedicine. 2024 Jun;128:155472. doi: 10.1016/j.phymed.2024.155472. Epub 2024 Feb 24. Phytomedicine. 2024. PMID: 38461630 Review.
-
A utility-based machine learning-driven personalized lifestyle recommendation for cardiovascular disease prevention.J Biomed Inform. 2023 May;141:104342. doi: 10.1016/j.jbi.2023.104342. Epub 2023 Mar 22. J Biomed Inform. 2023. PMID: 36963450
-
Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.Front Med (Lausanne). 2019 Sep 13;6:202. doi: 10.3389/fmed.2019.00202. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31616668 Free PMC article. Review.
-
Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease.Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102182. doi: 10.1016/j.cpcardiol.2023.102182. Epub 2023 Oct 30. Curr Probl Cardiol. 2024. PMID: 37913933 Review.
Cited by
-
Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome.Arch Intern Med Res. 2024;7(4):273-283. doi: 10.26502/aimr.0184. Epub 2024 Oct 28. Arch Intern Med Res. 2024. PMID: 39574946 Free PMC article.
References
-
- Haghighi K., Gardner G., Vafiadaki E., Kumar M., Green L.C., Ma J., Crocker J.S., Koch S., Arvanitis D.A., Bidwell P., et al. Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias. J. Pers. Med. 2021;11:502. doi: 10.3390/jpm11060502. - DOI - PMC - PubMed
-
- Rogalska M., Vafiadaki E., Erpapazoglou Z., Haghighi K., Green L., Mantzoros C.S., Hajjar R.J., Tranter M., Karakikes I., Kranias E.G., et al. Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts. Metabolism. 2023;138:155344. doi: 10.1016/j.metabol.2022.155344. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources